These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 308090)

  • 1. Cellular and molecular requirements for X-linked, hapten-specific B-cell blockade in CBA/N mice.
    Merchant B; Snippe H; Lizzio EF; Inman JK
    J Exp Med; 1978 Jun; 147(6):1755-70. PubMed ID: 308090
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hapten-specific blockade of CBA/N x C3H/HeN F1 B cell responses in a cell transfer system.
    Snippe H; Merchant B; Lizzio EF; Inman JK
    Int Arch Allergy Appl Immunol; 1980; 63(4):396-407. PubMed ID: 7000711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hapten-specific B cell blockade of the immune response to a thymus-independent-1 antigen produced by concomitant administration of a thymus-independent-2 antigen.
    Snippe H; Van Houte AJ; Inman JK; Lizzio EF; Merchant B
    Immunology; 1984 May; 52(1):87-96. PubMed ID: 6201438
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional antigen binding by the defective B cells of CBA/N mice.
    Snippe H; Merchant B; Lizzio EF; Inman JK
    Adv Exp Med Biol; 1982; 149():91-6. PubMed ID: 6983243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of accessory cells in B cell activation. III. Cellular analysis of primary immune response deficits in CBA/N mice: presence of an accessory cell-B cell interaction defect.
    Boswell HS; Nerenberg MI; Scher I; Singer A
    J Exp Med; 1980 Nov; 152(5):1194-309. PubMed ID: 6159444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of immunogenic properties of haptenated liposomal model membranes in mice. VII. Synergistic responses to haptenated liposomes and haptenated thymus-dependent antigens in CBA/N mice.
    Snippe H; Van Houte AJ; Janssen A; Lizzio EF; Willers JM; Merchant B
    Immunology; 1982 Apr; 45(4):613-20. PubMed ID: 6175564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. X-linked genetic control of hapten-polysaccharide-mediated specific immune unresponsiveness in CBA/N mice.
    Merchant B; Snippe H; Lizzio EF; Inman JK
    J Immunol; 1978 Apr; 120(4):1362-8. PubMed ID: 347000
    [No Abstract]   [Full Text] [Related]  

  • 8. B cell tolerance induced by polymeric antigens. II. Effects of tolerance on hapten-binding lymphocyte levels in primary and secondary antibody responses.
    Klaus GG
    Eur J Immunol; 1976 Jun; 5(6):366-72. PubMed ID: 10168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The specificity of in vivo tolerance to haptens in NZB and normal mice after exposure to hapten-modified syngeneic spleen cells.
    Cowdery JS; Laskin CA; Steinberg AD
    J Immunol; 1982 Apr; 128(4):1571-6. PubMed ID: 6174607
    [TBL] [Abstract][Full Text] [Related]  

  • 10. B cell tolerance induced by polymeric antigens. III. Dissociation of antibody formation and memory generation in tolerant mice.
    Klaus GG; Willcox HN
    Eur J Immunol; 1975 Oct; 5(10):699-704. PubMed ID: 11993338
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Murine B-cell subpopulations responsive to T-dependent and T-independent antigens.
    Lewis GK; Ranken R; Nitecki DE; Goodman JW
    J Exp Med; 1976 Aug; 144(2):382-97. PubMed ID: 1085326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synergistic effects of the xid gene in X chromosome congenic mice. I. Inability of C3.CBA/N mice to respond to thymus-dependent antigens in adoptive transfer assays.
    Kenny JJ; Guelde G; Hansen C; Mond JJ
    J Immunol; 1987 Mar; 138(5):1363-71. PubMed ID: 2949014
    [TBL] [Abstract][Full Text] [Related]  

  • 13. B cell tolerance induced by polymeric antigens. IV. Antigen-mediated inhibition of antibody-forming cells.
    Klaus GG
    Eur J Immunol; 1976 Mar; 6(3):200-7. PubMed ID: 1086775
    [TBL] [Abstract][Full Text] [Related]  

  • 14. B cell tolerance induced by polymeric antigens. I. Comparison of the dose and epitope density requirements for inactivation of primed and unprimed B cells in vivo.
    Klaus GG; Humphrey JH
    Eur J Immunol; 1976 Jun; 5(6):361-5. PubMed ID: 10167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunopotentiation by SGP and Quil A. II. Identification of responding cell populations.
    Flebbe LM; Braley-Mullen H
    Cell Immunol; 1986 Apr; 99(1):128-39. PubMed ID: 3489558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epitope-specific regulation. I. Carrier-specific induction of suppression for IgG anti-hapten antibody responses.
    Herzenberg LA; Tokuhisa T
    J Exp Med; 1982 Jun; 155(6):1730-40. PubMed ID: 6176665
    [TBL] [Abstract][Full Text] [Related]  

  • 17. X-linked B-lymphocyte immune defect in CBA/N mice. II. Studies of the mechanisms underlying the immune defect.
    Scher I; Steinberg AD; Berning AK; Paul WE
    J Exp Med; 1975 Sep; 142(3):637-50. PubMed ID: 1080788
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hapten-specific leukocyte migration inhibition. I. Inhibition of cells from animals immunized with DNP-KLH by epsilon-DNP-L-lysine Ficoll.
    McMaster PR; Owens JD; Asofsky R
    J Immunol; 1977 Apr; 118(4):1335-7. PubMed ID: 300405
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carrier-specific immune memory to a thymus-independent antigen in congenitally athymic mice.
    Schott CF; Merchant B
    J Immunol; 1979 May; 122(5):1710-8. PubMed ID: 376725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Murine in vivo carrier-specific IgG memory to DNP-Ficoll: variation among inbred strains.
    Shott CF; Merchant B
    J Immunogenet; 1982 Aug; 9(4):277-80. PubMed ID: 6181174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.